T1 glottic laryngeal cancer: the role of routine follow-up visits in detecting local recurrence

Abstract

<p>Purpose We assessed the treatment outcome and the benefts of routine follow-up visits in T1 glottic laryngeal squamous<br>cell carcinoma (LSCC).<br>Methods: Medical records of patients diagnosed with stage T1 glottic LSCC (N=303) in fve Finnish university hospitals between 2003 and 2015 were reviewed. Moreover, data from the Finnish Cancer Registry and the Population Register Center were collected.<br>Results: Of all 38 recurrences, 26 (68%) were detected during a routine follow-up visit, and over half (21 of 38, 55%) presented without new symptoms. Primary treatment method (surgery vs. radiotherapy) was not connected with 5-year diseasespecifc survival (DSS) or laryngeal preservation rate.<br>Conclusion: The majority of recurrences were detected on a routine follow-up visit, and local recurrences often presented without new symptoms. Routine post-treatment follow-up of T1 glottic LSCC seems benefcial.<br>Trial registration Trial registration number and date of registration HUS/356/2017 11.12.2017.<br></p>